SCYNEXIS is a premier drug discovery and development company delivering effective and innovative drug pipeline solutions to human and animal health pharmaceutical and global health partners. Our drug discovery and development services take your compounds from concept to clinic with speed and innovation. They are available on a fee for service basis or may be conducted in a shared risk arrangement. SCYNEXIS has also built a proprietary pipeline of novel drug candidates that are based on the exciting new area of cyclophilin inhibition. Cyclophilin inhibitors represent a class of drugs that hold significant potential for the treatment of a broad range of diseases.